IRONWOOD PHARMACEUTICALS INC (IRWD)
US46333X1081 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to IRWD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.36. This target is 135.69% above the current price.
IRWD was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IRWD.
In the previous month the buy percentage consensus was at a similar level.
IRWD was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-01-17 | Craig-Hallum | Initiate | Buy |
| 2023-12-14 | Wells Fargo | Initiate | Overweight |
| 2023-09-28 | JMP Securities | Initiate | Market Outperform |
| 2023-05-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2022-08-16 | Wells Fargo | Maintains | Equal-Weight |
| 2022-04-22 | Piper Sandler | Initiate | Overweight |
| 2021-10-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-16 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-22 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-19 | Morgan Stanley | Maintains | Equal-Weight |